Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by H. Esra Ataoglu
Sodium Glucose Cotransporter-2 (SGLT-2) Inhibitor Related Diabetic Ketoacidosis
European Scientific Journal ESJ
Related publications
Ertugliflozin: A Sodium-Glucose Cotransporter-2 (SGLT-2) Inhibitor for Glycemic Control in Type 2 Diabetes
Therapeutics and Clinical Risk Management
Euglycemic Diabetic Ketoacidosis Induced by Empagliflozin, Sodium-Glucose Cotransporter-2 Inhibitor, in Patient With Diabetes Mellitus Type 2 After Thoracic Surgery
Lijecnicki Vjesnik
Medicine
Euglycemic Diabetic Ketoacidosis With Prolonged Glucosuria Associated With the Sodium-Glucose Cotransporter-2 Canagliflozin
Journal of Investigative Medicine High Impact Case Reports
Risk
Epidemiology
Reliability
Safety
Safety Research
Quality
Relationship Between Euglycemic Diabetic Ketoacidosis and SGLT-2 Inhibitors
Global Journal of Endocrinological Metabolism
The Sodium–Glucose Cotransporter 2 Inhibitor Dapagliflozin Prevents Cardiomyopathy in a Diabetic Lipodystrophic Mouse Model
Diabetes
Internal Medicine
Endocrinology
Metabolism
Diabetes
Sodium–glucose Co-Transporter 2 Inhibitors: Think Twice About Diabetic Ketoacidosis
Cardiovascular Effects of Sodium Glucose Cotransporter 2 Inhibitors
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy
Internal Medicine
Pharmacology
Increased Grip Strength With Sodium-Glucose Cotransporter 2
Journal of Diabetes
Endocrinology
Metabolism
Diabetes
Hemodynamic Effects of Sodium-Glucose Cotransporter 2 Inhibitors
Journal of Clinical Medicine Research